Skip to content
Latest ENETS Guidelines
My Diagnosis and Treatment
My Neuroendocrine Cancer Surgery – Small Intestine NET, a patient experience (part 1)
My Neuroendocrine Cancer Surgery – a patient experience (part 2)
My liver rescetion
Neuroendocrine Cancer: My experience with Lanreotide (Somatuline Autogel/Depot)
Ronny’s Video Presentations
WEGO Health Patient Leader
Join the Support Group
Award Winning Blog
Neuroendocrine tumors are uncommon but definitely not rare
Neuroendocrine Neoplasms – not as rare as you think
The Invisible NET Patient Population
Neuroendocrine Neoplasms (NEN) – genetic related syndromes
A spotlight on Multiple Endocrine Neoplasia (MEN)
Diagnosis and Surveillance
Neuroendocrine Neoplasms – Grade and Stage (incorporating WHO 2021 changes)
Where to find a NET Specialist worldwide
10 questions to ask your doctor
Diagnosing the Undiagnosed
A needle in a haystack?
A spotlight on NENs
A spotlight on NENs – Types
A spotlight on Appendiceal Neuroendocrine Neoplasms
A spotlight on Gastric Neuroendocrine Neoplasms
A spotlight on duodenal Neuroendocrine Neoplasms (dNENs)
A spotlight on Rectal Neuroendocrine Neoplasms
A Spotlight on Lung Neuroendocrine Neoplasms
Neuroendocrine Tumours: a spotlight on Pheochromocytoma and Paraganglioma
A spotlight on Grade 3 (High grade) Neuroendocrine Neoplasms
A spotlight on NENs – Syndromes
A Spotlight on Neuroendocrine Cancer Syndromes – Carcinoid Syndrome
A Spotlight on NENs – Testing
Tumour markers and Hormone Levels
A spotlight on Chromogranin A
A spotlight on 5-HIAA
The NETest® – a Chromogranin A replacement and more?
Syndromes and Symptoms
I bet my flush beats yours?
Neuroendocrine Cancer – the diarrhea jigsaw
The Syndromes of Neuroendocrine Cancer – Early Signs of a Late Diagnosis
Neuroendocrine Cancer: Clinical Esoterica
Serotonin – the NET effect
Cancer-related fatigue (CRF) – Neuroendocrine Cancer
Neuroendocrine Cancer – If you can see it, you can detect it!
Gallium 68 PET Scans – Into the Unknown
Ga68 PET Scan – a game changer?
Detectnet™ (64Cu-DOTATATE) – an expansion of the Somatostatin Receptor PET Imaging for Neuroendocrine Cancer
Neuroendocrine Tumours – now you see them, now you don’t!
Understanding your Somatostatin Receptor (SSTR) PET Results
Treatment – a summary for patients
Surgery for Neuroendocrine Neoplasms – to cut or not to cut?
Surgery for NETs – Chop Chop
Surgery is risky but so is driving a car
Small intestine, large surgery
Small Intestine Neuroendocrine Tumours (SI NETs): To cut or not to cut?
Pancreatic Neuroendocrine Tumours – surgical decisions
Neuroendocrine Cancer – my liver surgery
Liver Embolization (bland, chemo, radio)
Peptide Receptor Radionuclide Therapy (PRRT)
Selecting patients and the Challenges of Evaluating Response to PRRT in GEPNETs: The Present and the Future
Somatostatin Analogues for Neuroendocrine Cancer: Lanreotide and Octreotide
Lanreotide – it’s calling the shots!
At home with Lanreotide (….and Octreotide)
Somatostatin Analogues and delivery methods in the pipeline
Telotristat Ethyl (XERMELO®)
Diet & Nutrition
Article 1 – Vitamin and Mineral Challenges
Article 2 – Gastrointestinal Malabsorption
Article 3 – Gut Health
Article 4 – Food for Thought?
Article 5 – Pancreatic Enzyme Replacement Therapy (PERT)
Article 6 – featuring the 2020 video series by Tara Whyand RD
Q. The best diet for Neuroendocrine Cancer? A. The one that works for you.
Lactose intolerance – the NET Effect
Fructose intolerance – the NET Effect
Low FODMAPs – The NET Effect
The trouble with the NET (Part 5) – Cancer Diet Myths
The NET Effect Series
Clinical Trials and Research
Glossary of Terms (A to Z)
Subscribe to Newsletter
Take some time to browse the most popular articles
Subscribe to my Newsletter
What is trending on RonnyAllan.NET?
Read my Glossary of Terms